Biotechnology firm Biogen Inc. (NASDAQ: BIIB) on Thursday reported higher revenues and adjusted profit for the second quarter of 2025. The company also raised its FY25 guidance to reflect a stronger business outlook for the year.
Total revenue rose 7% year-over-year to $2.65 billion in the June quarter. For the full year of 2025, the company expects revenues to be broadly flat, at constant currency, versus full year 2024, which is up from a mid-single digit decline it forecast previously.
Net income attributable to Biogen was $634.8 million or $4.33 per share in Q2, compared to $583.6 million or $4.0 per share in the second quarter of 2024. Adjusted earnings increased 4% annually to $5.47 per share in the second quarter.
The management raised its full-year adjusted earnings per share guidance to the range of $15.50 to $16.00 from the earlier outlook of $14.50-15.50.
Biogen’s CEO. Christopher Viehbacher said, “We delivered another quarter of strong execution against our strategy to transform our portfolio and build the new Biogen. Our performance reflects robust financial results, ongoing cost discipline, continued growth of our launch products, and meaningful strides in expanding and advancing our late-stage pipeline.“
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key metrics from Kroger’s (KR) Q3 2025 earnings results
The Kroger Co. (NYSE: KR) reported its third quarter 2025 earnings results today. Total company sales rose to $33.9 billion from $33.6 billion in the same period last year. Identical
Dollar General (DG) Q3 2025 Earnings: Key financials and quarterly highlights
Dollar General Corporation (NYSE: DG) reported its third quarter 2025 earnings results today. Net sales increased 4.6% year-over-year to $10.65 billion. Same-store sales increased 2.5%. Net income was $282.7 million, or
HRL Earnings: All you need to know about Hormel Foods’ Q4 2025 earnings results
Hormel Foods Corporation (NYSE: HRL) reported its fourth quarter 2025 earnings results today. Net sales increased 1.5% year-over-year to $3.18 billion. Organic sales were up 2%. Net loss attributable to Hormel
